The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients

Journal of Antimicrobial Chemotherapy

Volumn 33, Issue 2, 1994, Pages 309-318

  Chandrasekar, Pranatharthi H ^a,b   Gatny, Cynthia M ^a,b  

^a Hematology Oncology Liaison Unit ^*  (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; FLUCONAZOLE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CARRIER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALE; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OROPHARYNX; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECTUM;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CANDIDA; CANDIDIASIS; COLONY COUNT, MICROBIAL; DOUBLE-BLIND METHOD; FEMALE; FLUCONAZOLE; HUMANS; LEUKEMIA; MALE; MYCOSES; NEUTROPENIA; OROPHARYNX; PREMEDICATION; RECTUM; YEASTS;

EID: 0028328974     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/33.2.309     Document Type: Article

References (30)

1. Aisner, J., Schimpft, S. C., Sutherland, J. C., Young, V. M. and Wiemik, P. H. (1976). Torulopsis glabrata infections in patients with cancer: increasing incidence and relationship to colonization. American Journal of Medicine 61, 23-8.
2. Bodey, G. P. (1969). The effect of amphotericin B on the fungal flora in feces. Clinical Pharmacology and Therapeutics 10, 675-80.
3. Bodey, G. P. (1984). Candidiasis in cancer patients. American Journal of Medicine 77, Suppl. 4D, 13-9.
4. Bodey, G. P., Samonis, G. and Rolston, K. (1980). Prophylaxis of candidiasis in cancer patients. Seminars in Oncology 17, Suppl. 6, 24-8.
5. Casasnovas, R. O., Caillot, D., Solary, E., Bonotte, B., Chavanet, P. and Bonin, A. et al. (1992). Prophylactic fluconazole and Candida krusei infections. New England Journal of Medicine 336, 891-2.
6. Case, C. P., MacGowan, A. P., Brown, N. M., Reeves, D. S., Whitehead, P. and Felmingham D. (1991). Prophylactic oral fluconazole and Candida fungaemia. Lancet 337, 790.
7. Cuttner, J., Troy, K. M., Funaro, L., Brenden, R. and Bottone, E. J. (1986). Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy: results of a double-blind study. American Journal of Medicine 81, 771-4.
8. DeJongh, C., Finley, R., Joshi, J., Newham, K., Wiemik, P. and Schimpff, S. (1983). A comparison of ketoconazole to nystatin: prophylaxis of fungal infection in neutropenic patients. In Program and Abstracts of the Twenty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 497. American Society for Microbiology, Washington, DC.
9. Donnelly, J. P., Starke, I. D., Galton, D. A. G., Catovsky, D., Goldman, J. M. and Darrell, J. H. (1984). Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. Journal of Hospital Infection 5, 83-91.
10. Eng, R. H. K., Drehmel, R., Smith, S. M. and Goldstein, E. J. (1984). Saccharomyces cerevisiae infection in man. Sabouradia 22, 403-7.
11. Eschete, M. L. and West B. C. (1980). Saccharomyces cerevisiae septicemia. Archives of Internal Medicine 140, 1539.
12. Ezdinli, E. Z., O’Sullivan, D. D., Wasser, L. P., Kim, U. and Stutzman, L. (1979). Oral amphotericin for candidiasis in patients with hematologic neoplasms, an autopsy study. Journal of the American Medical Association 242, 258-60.
13. Goodman, J. L., Winston, D. L., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-51.
14. Grant, S. M. and Clissold, S. P. (1990). Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39, 877-916.
15. Hann, I. M., Prentice, H. G., Corringham, R., Blacklock, H. A., Keaney, M. and Shannon, M. et al. (1982). Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet i, 826-9.
16. Horn, R., Wong, B., Kiehn, T. E. and Armstrong, D. (1985). Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Reviews of Infectious Diseases 7, 646-55.
17. Komshian, S. V., Uwaydah, A. K., Sobel, J. D. and Crane, L. R. (1989). Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Reviews of Infectious Diseases 11, 379-90.
18. Mcllroy, M. A. (1991). Failure of fluoconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. Journal of Infectious Diseases 163, 420-1.
19. Meunier, F. (1987). Prevention of mycoses in immuncompromised patients. Reviews of Infectious Diseases 9, 408-16.
20. Nielsen, H., Stenderup, J. and Bruun, B. (1990). Fungemia with Saccharomycetaceae. Report of four cases and review of the literature. Scandinavian Journal of Infectious Diseases 22, 581-4.
21. Owens, N. J., Nightingale, C. H., Schweizer, R. T., Schauer, P. K., Dekker, P. T. and Quintiliani, R. (1984). Prophylaxis of oral candidiasis with clotrimazole troches. Archives of Internal Medicine 144, 290-3.
22. Persons, D. A., Laughlin, M., Tanner, D., Perfect, J., Gockerman, J. P. and Hathom, J. W. (1991). Fluconazole and Candida krusei fungemia. New England Journal of Medicine 325, 1315.
23. Sethi, N. and Mandell, W. (1988). Saccharomyces fungemia in a patient with AIDS. New York State Journal of Medicine 88, 278-9.
24. Shepp, D. H., Klosterman, A., Siegel, M. S. and Meyers, J. D. (1985). Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. Journal of Infectious Diseases 152, 1257-63.
25. Stein, P. D., Folkens, A. T. and Hruska, K. A. (1970). Saccharomyces fungemia. Chest 58, 173-5.
26. Wamock, D. W., Burke, J., Cope, N. J., Johnson, E. M., von Fraunhofer, N. A. and Williams, E. W. (1988). Fluconazole resistance in Candida glabrata. Lancet ii. 1310.
27. Wingard, J. R„ Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. and Sarai, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.
28. Wingard, J. R., Merz, W. G. and Sarai, R. (1979). Candida tropicalis: a major pathogen in immuncompromised patients. Annals of Internal Medicine 91, 539-43.
29. Wingard, J. R., Vaughan, W. P., Braine, H. G., Merz, W. and Sarai, R. (1987). Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebocontrolled trial of intravenous miconazole. American Journal of Medicine 83, 1103-10.
30. Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L. and Horowitz, H. et al. (1993). Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized, placebo-controlled, double blind, multicenter trial. Annals of Internal Medicine 118, 495-503.